Loading...
Entry LevelFull-time
Salary Range
$25,500 - $34,500 /year
This salary is estimated based on similar roles. The actual salary may vary.
As a Senior Finance Analyst, you will serve as a strategic finance business partner to AbbVie’s legal organization, focusing on legal fee management, budget planning, and driving continuous process improvements. You will collaborate with cross-functional teams (finance, attorneys, legal operations, accounts payable) to support settlement payments, month-end close activities, accurate forecasts, and process enhancements in the legal finance area.
Responsibilities
• Prepare journal entries, reconciliations, and financial reports for month-end close.
• Aid the Finance Manager with OEC forecast responsibilities.
• Manage large data sets for forecasts, working with attorneys to finalize LBEs and Annual Plans.
• Act as primary contact for insurance-backed legal matters, maintaining impact summaries and supporting carrier invoicing.
• Conduct ad-hoc financial analyses as needed.
• Produce monthly and quarterly finance reports (e.g., Passport Report for Deal Fees, Legal Fee Aging Report, New Matter Report, Legal Ops Spend Report).
• Perform quarterly compliance audits and maintain legal fee balance sheet sweeps.
• Support settlement payments (< $10MM).
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
